Ependymoma Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Synergistic effect of poly (ADP-ribose) polymerase (PARP) inhibitor with chemotherapy on CXorf67-elevated posterior fossa group A ependymoma
Chin Med J (Engl). 2024 Mar 13. doi: 10.1097/CM9.0000000000003040. Online ahead of print.NO ABSTRACTPMID:38479992 | DOI:10.1097/CM9.0000000000003040 (Source: Chinese Medical Journal)
Source: Chinese Medical Journal - March 13, 2024 Category: General Medicine Authors: Jichang Han Jianzhong Yu Meng Yu Yachao Liu Xiaomin Song Hao Li Lin Li Source Type: research

Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience
CONCLUSION: Incorporating radiotherapy into multimodal treatment has led to favorable outcomes in patients with ependymoma, and the extent of resection is a prognostic factor for the local control of intracranial ependymoma.PMID:38471461 | DOI:10.1159/000538321 (Source: Oncology)
Source: Oncology - March 12, 2024 Category: Cancer & Oncology Authors: Tiffany Ting-Fong Liu Jason Chia-Hsien Cheng Yu-Hsuan Chen Feng-Ming Hsu Keng-Hsueh Lan Chao-Yuan Huang Chun-Wei Wang Sung-Hsin Kuo Source Type: research

Primary extraskeletal intradural Ewing sarcoma with acute hemorrhage: a case report and review of the literature
ConclusionsIntradural extraskeletal Ewing sarcoma is an infrequently encountered condition in adult patients, emphasizing the importance of considering it in the differential diagnosis of spinal tumors. Surgeons must possess a comprehensive understanding of this rare entity to ensure accurate staging and optimal management, particularly in the early stages when prompt intervention may improve prognosis. (Source: Journal of Medical Case Reports)
Source: Journal of Medical Case Reports - March 9, 2024 Category: General Medicine Source Type: research

Recurrence Patterns and Surveillance Imaging in Pediatric Brain Tumor Survivors
This study included 476 patients with the majority diagnosed with low-grade glioma (LGG) (n=138, 29%), high-grade glioma (HGG) (n=77, 16%), ependymoma (n=70, 15%), or medulloblastoma (n=61, 13%). LGG, HGG, and ependymoma patients more commonly had multiply recurrent disease (P=0.08), with ependymoma patients demonstrating ≥2 relapses in 47% of cases. Recurrent disease was identified by imaging more often than clinical symptoms (65% vs. 32%; P=<0.01). Patients diagnosed with meningioma demonstrated the longest mean time to first relapse (74.7 mo) whereas those with atypical teratoid rhabdoid tumor and choroid plexus ca...
Source: Ann Oncol - March 6, 2024 Category: Cancer & Oncology Authors: Chantel Cacciotti Alicia Lenzen Chelsea Self Natasha Pillay-Smiley Source Type: research